Rydapt Midostaurin — Medica
8 indications indexed for this drug.
- Acute Myeloid LeukemiaView coverage criteria
- Aggressive Systemic MastocytosisView coverage criteria
- Indolent Systemic MastocytosisView coverage criteria
- Lymphoid NeoplasmsView coverage criteria
- Mast Cell LeukemiaView coverage criteria
- Myeloid NeoplasmsView coverage criteria
- Smoldering Systemic MastocytosisView coverage criteria
- Systemic Mastocytosis With Associated Hematological NeoplasmView coverage criteria